Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Immunovant Inc (NASDAQ: IMVT) closed the day trading at $15.20 down -11.06% from the previous closing price of $17.09. In other words, the price has decreased by -$11.06 from its previous closing price. On the day, 3.71 million shares were traded. IMVT stock price reached its highest trading level at $17.09 during the session, while it also had its lowest trading level at $15.0.
Ratios:
For a better understanding of IMVT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Fromkin Andrew J. sold 8,000 shares for $19.60 per share. The transaction valued at 156,769 led to the insider holds 91,913 shares of the business.
ANDREW J FROMKIN bought 8,000 shares of IMVT for $156,160 on Mar 07 ’25. On Feb 19 ’25, another insider, Macias William L., who serves as the Chief Medical Officer of the company, sold 2,055 shares for $20.86 each. As a result, the insider received 42,867 and left with 357,353 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 2581886976 and an Enterprise Value of 2207220480.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.81, which has changed by -0.51250803 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $16.72. The 50-Day Moving Average of the stock is -24.47%, while the 200-Day Moving Average is calculated to be -42.28%.
Shares Statistics:
Over the past 3-months, IMVT traded about 1.49M shares per day on average, while over the past 10 days, IMVT traded about 3077850 shares per day. A total of 147.20M shares are outstanding, with a floating share count of 69.37M. Insiders hold about 59.16% of the company’s shares, while institutions hold 49.44% stake in the company. Shares short for IMVT as of 1741910400 were 15799702 with a Short Ratio of 10.57, compared to 1739491200 on 14788106. Therefore, it implies a Short% of Shares Outstanding of 15799702 and a Short% of Float of 18.059998999999998.
